These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8101096)

  • 1. Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
    Van Rooij J; Schoemaker HC; Bruno R; Reinhoudt JF; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Jun; 35(6):661-3. PubMed ID: 8101096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M; Sakashita M; Mizuki Y; Yamaguchi T; Fujii T; Sekine Y
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.
    Noveck RJ; Preston RA; Swan SK
    Clin Pharmacokinet; 2007; 46(6):525-34. PubMed ID: 17518511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.
    Lasseter KC; Dilzer SC; Vargas R; Waldman S; Noveck RJ
    Clin Pharmacokinet; 2004; 43(2):121-9. PubMed ID: 14748620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and electrocardiographic effect of ebastine in young versus elderly healthy subjects.
    Huang MY; Argenti D; Wilson J; Garcia J; Heald D
    Am J Ther; 1998 May; 5(3):153-8. PubMed ID: 10099053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of food on the bioavailability of ebastine.
    Pentikis HS; Huang MY; Dorr MB; Heald DL
    Am J Ther; 1997; 4(2-3):80-4. PubMed ID: 10423596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
    Chaikin P; Gillen MS; Malik M; Pentikis H; Rhodes GR; Roberts DJ
    Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of ebastine in children.
    Simons FE; Watson WT; Simons KJ
    J Pediatr; 1993 Apr; 122(4):641-6. PubMed ID: 8096545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
    Vincent J; Liminana R; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1988 Nov; 26(5):497-502. PubMed ID: 2905150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole and rifampin alter significantly the disposition and antihistamine effect of ebastine and its metabolites in healthy participants.
    Shon JH; Yeo CW; Liu KH; Lee SS; Cha IJ; Shin JG
    J Clin Pharmacol; 2010 Feb; 50(2):195-204. PubMed ID: 19841159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.
    Puigdemont A; Queralt M; Jansat JM; Martinez-Tobed A
    J Pharm Pharmacol; 1994 Jul; 46(7):596-9. PubMed ID: 7996390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac effects of ebastine and other antihistamines in humans.
    Moss AJ; Morganroth J
    Drug Saf; 1999; 21 Suppl 1():69-80; discussion 81-7. PubMed ID: 10597870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
    Tamai I; Kido Y; Yamashita J; Sai Y; Tsuji A
    J Drug Target; 2000; 8(6):383-93. PubMed ID: 11328664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects.
    Mattila MJ; Kuitunen T; Plétan Y
    Eur J Clin Pharmacol; 1992; 43(2):179-84. PubMed ID: 1358620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration.
    Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Fujii T; Komemushi S; Itoh M; Sasaki H; Watanabe T; Yanai K
    Br J Clin Pharmacol; 2002 Mar; 53(3):296-304. PubMed ID: 11874393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine.
    Mattila MJ; Aranko K; Kuitunen T
    Br J Clin Pharmacol; 1993 Mar; 35(3):272-7. PubMed ID: 8097102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.